Literature DB >> 11293527

Pretreatment with glycine reduces the severity of warm intestinal ischemic-reperfusion injury in the rat.

M A Lee1, R D McCauley, S E Kong, J C Hall.   

Abstract

Free jejunal flaps may experience adverse effects immediately after revascularization because of ischemic-reperfusion injury. In this study the authors evaluated the ability of glycine to protect the small intestine against the effects of a warm ischemic-reperfusion injury. Male Wistar rats (N = 30) were randomized to either a baseline group (no intervention), a control group (local arterial infusion with normal saline), or a glycine group (local arterial infusion with 20% glycine). Pretreatment with 20% glycine increased significantly (p < 0.05) mucosal protein and deoxyribonucleic acid content, reduced intestinal myeloperoxidase activity, and maintained mucosal glutaminase activity. These results indicate that some of the indicators of ischemic-reperfusion injury are improved by pretreatment with a 20% glycine solution.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11293527     DOI: 10.1097/00000637-200103000-00020

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  10 in total

1.  Cytoprotection by glycine against ATP-depletion-induced injury is mediated by glycine receptor in renal cells.

Authors:  Chao Pan; Xiaoming Bai; Leming Fan; Yong Ji; Xiaoyu Li; Qi Chen
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

Review 2.  Glycine, a simple physiological compound protecting by yet puzzling mechanism(s) against ischaemia-reperfusion injury: current knowledge.

Authors:  Frank Petrat; Kerstin Boengler; Rainer Schulz; Herbert de Groot
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

3.  Anti-inflammatory role of glycine in reducing rodent postoperative inflammatory ileus.

Authors:  B Stoffels; A Türler; J Schmidt; A Nazir; T Tsukamoto; B A Moore; C Schnurr; J C Kalff; A J Bauer
Journal:  Neurogastroenterol Motil       Date:  2010-10-01       Impact factor: 3.598

4.  Glycine transporter GLYT1 is essential for glycine-mediated protection of human intestinal epithelial cells against oxidative damage.

Authors:  Alison Howard; Imran Tahir; Sajid Javed; Sarah M Waring; Dianne Ford; Barry H Hirst
Journal:  J Physiol       Date:  2010-02-01       Impact factor: 5.182

Review 5.  Ischemia-reperfusion injury of the intestine and protective strategies against injury.

Authors:  Ismail Hameed Mallick; Wenxuan Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

6.  A prospective randomized trial of enteral glutamine in critical illness.

Authors:  John C Hall; Geoffrey Dobb; Jane Hall; Ruth de Sousa; Lisa Brennan; Rosalie McCauley
Journal:  Intensive Care Med       Date:  2003-08-16       Impact factor: 17.440

Review 7.  Small bowel review: Diseases of the small intestine.

Authors:  Alan B R Thomson; Laurie Drozdowski; Claudiu Iordache; Ben K A Thomson; Severine Vermeire; M Tom Clandinin; Gary Wild
Journal:  Dig Dis Sci       Date:  2003-08       Impact factor: 3.487

Review 8.  Glycinergic Signaling in Macrophages and Its Application in Macrophage-Associated Diseases.

Authors:  Zhending Gan; Meiyu Zhang; Donghui Xie; Xiaoyan Wu; Changming Hong; Jian Fu; Lijuan Fan; Shengyi Wang; Sufang Han
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

9.  Glycine and glycine receptor signalling in non-neuronal cells.

Authors:  Jimmy Van den Eynden; Sheen Saheb Ali; Nikki Horwood; Sofie Carmans; Bert Brône; Niels Hellings; Paul Steels; Robert J Harvey; Jean-Michel Rigo
Journal:  Front Mol Neurosci       Date:  2009-08-20       Impact factor: 5.639

10.  Glycine attenuates myocardial ischemia-reperfusion injury by inhibiting myocardial apoptosis in rats.

Authors:  Xiaozheng Zhong; Xiaoyu Li; Lingling Qian; Yiming Xu; Yan Lu; Jing Zhang; Nan Li; Xudong Zhu; Jingjing Ben; Qing Yang; Qi Chen
Journal:  J Biomed Res       Date:  2012-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.